[Severe anemia requiring transfusion in the early stage of low-grade malignant non-Hodgkin's lymphoma].
Südhoff
T
T
Heinrich-Heine-Universität, Abteilung für Hämatologie, Onkologie und klinische Immunologie, Düsseldorf.
Aul
C
C
Kretschmer
S
S
Söhngen
D
D
Runde
V
V
D001853:Bone Marrow / Q000473:pathology; D003131:Combined Modality Therapy; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D017707:Erythrocyte Transfusion; D004912:Erythrocytes / Q000473:pathology; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000473:pathology / Q000628:therapy*; D008875:Middle Aged; D012010:Red-Cell Aplasia, Pure / Q000473:pathology / Q000628:therapy*
D016572:Cyclosporine
Schwere transfusionspflichtige Anämie im Frühstadium eines niedrig-malignen Non-Hodgkin-Lymphoms.